enGenes showcasing X-Press and R&D highlights and opportunities at BIO-Europe 2018


enGenes showcasing X-Press and R&D highlights and opportunities at BIO-Europe 2018


engenes_Logo_final1

Press Release | enGenes Biotech GmbH

OCTOBER 23, 2018

Vienna, Austria: – Recombinant protein specialist manufacturer enGenes Biotech GmbH (enGenes) is returning for a fourth successive year to Europe’s leading partnering event, BIO-Europe, to present its latest biotech technologies and opportunities.

The enGenes presence at the Bella Center in the Danish capital, Copenhagen, will be led by CEO Juergen Mairhofer. They will highlight their advanced protein production technologies and the company’s newly designed service portfolio, designed to provide a wide range of realistic options for companies looking to develop cost-effective manufacturing processes for recombinant proteins.

F&E collaborations

“We are delighted to be returning to BIO-Europe, a conference we have attended every year since 2014,” said Dr. Mairhofer.

“For enGenes, this event is one of the highlights of our year and an excellent platform for meeting existing and potential new clients, discussing new research & development (R&D) partnerships and collaboration opportunities to apply our leading-edge technologies for protein production and development,” he added.

Powerful production processes

enGenes-X-press™ technology enhances the power of protein expression and production with growth-decoupled protein production in Escherichia coli (E.coli), enabling rapid development of economic, scalable and efficient production processes.

enGenes also offers a modular service model focused on the expression of difficult-to-express proteins covering all specific demands along the line from gene to protein, from cloning and vector optimization through to final purification.

Cost-effective protein manufacturing

“In summary, we can provide very cost-effective manufacturing solutions with a dedicated team of experts used to solve our clients technical issues,” said Juergen Mairhofer.

“We are inviting any potential partners clients who wish to explore possible collaborations to get in touch with us via the partneringONE platform to arrange face-to-face discussions in Copenhagen,” he added.

About enGenes Biotech

enGenes Biotech GmbH (enGenes) is a contract research, development and manufacturing company that provides leading edge technologies and production services focused on recombinant proteins in bacteria. The company’s mission is to provide cost-effective and scalable production of recombinant proteins at a fraction of current cost, allied to a vision of developing a world-class portfolio of cutting-edge protein production technologies, relevant to a broad spectrum of application fields.

enGenes has developed advanced technologies to drive more cost-effective recombinant protein production processes., including its proprietary enGenes-X-press™ E. coli platform that achieves outstanding yields of soluble and active recombinant protein. enGenes-X-press has been successful applied for the manufacturing of enzymes and biopharmaceutical products that failed to give economically feasible yields in a conventional expression host.

enGenes Biotech offers development and manufacturing services tailored around the needs of pharmaceutical and industrial biotech companies. The services include expression strain and vector development, fermentation process development and optimization, downstream process development, production of purified protein, technology transfer and scale-up support with technology out-licensing and co-development opportunities.

About BIO-Europe 2018

The BIO-Europe® Conference is Europe’s largest partnering event serving the global biotechnology industry, providing life science companies with high caliber knowledge sharing and partnering opportunities.

The 24th BIO-Europe Conference is a three-day event opening November 5 at the Bella Center, Copenhagen.

BIO-Europe 2018 will attract more than 4,000 industry attendees from some 60 countries, representing more than 2,100 companies for three days of high level networking. Partnering is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners, and identify and pre-arrange private one-to-one meetings with multiple company targets.

BIO-Europe is organized by EBD Group and KNECT 365 with further information at: https://ebdgroup.knect365.com/bioeurope/about-bio-europe

Media Contact

Dr. Juergen Mairhofer, CEO, enGenes Biotech
Tel: +43 1 93 46 707-0
Email: office@engenes.cc

Resources

Click on enGenes at BIO-Europe 2018 for more information.
Click on enGenes Biotech GmbH to contact the company directly.


Supplier Information
Supplier: enGenes Biotech GmbH
Address: Mooslackengasse 17, 1190 Vienna, Austria
Tel: +43 1 93 46 707-0
Website: http://www.engenes.cc


Comments are closed.